Blog
58. Deep Research Into the Gut Microbes That Keep Us Happy | Jennifer Bramen, PhD
by Anthony Effinger
This episode of the ThinkNeuro Podcast features Dr. Jennifer Bramen, a neuroscientist at Pacific Neuroscience Institute, as she explores the powerful connection between gut microbes and brain health. Discover how the gut’s nervous system and its bacteria impact our mood and stress levels, and learn practical tips on how to support a healthy gut-brain connection through mindful eating. Tune in to hear Dr. Bramen's insights and research on this fascinating topic.
Preparing for Ketamine-Assisted Psychotherapy
by Zara Jethani
Preparation for ketamine-assisted psychotherapy (KAP) involves several key components aimed at ensuring the safety and efficacy of the treatment, as well as preparing the patient mentally and emotionally for the experience. Keep reading.
A New Patient’s Guide to Ketamine-Assisted Psychotherapy
by Zara Jethani
In recent years, ketamine-assisted psychotherapy (KAP) has emerged as a promising treatment for various mental health conditions, offering new hope to individuals who have not found relief through conventional therapies. Learn more.
Navigating New Frontiers: Exploring Psychedelic-Assisted Therapy at TRIP | Micah Linton, PsyD & Juliana Hudson, LCSW
by Anthony Effinger
This episode of the ThinkNeuro Podcast join us as we delve into this paradigm shift, uncovering how PNI is blazing a trail in the realm of psychedelic-assisted therapies.
Maximizing the Benefits of Ketamine Therapy through Integration
by Brianna Rauchman
Ketamine-assisted psychotherapy (KAP) is emerging as a significant therapeutic approach for various mental health conditions. However, the efficacy of KAP is greatly enhanced when coupled with a crucial component: integration. Learn how Pacific Neuroscience Institute® (PNI®)'s Treatment & Research in Psychedelics (TRIP) Center uses integration to optimize patient outcomes.
Unveiling the Benefits of Ketamine-Assisted Psychotherapy
by PNI Experts
Explore the transformative benefits of ketamine therapy in treating treatment-resistant depression, anxiety disorders, PTSD, chronic pain, and addiction. Learn how Pacific Neuroscience Institute's expert team harnesses the potential of ketamine to offer hope and relief.
Nature-Themed Psychedelic Therapy for Alcohol Addiction: Promising Findings Using Renowned Filmmaker’s Videos
by Guest Author
Immersive nature videos may enhance psychedelic-assisted therapy for alcohol addiction, according to research by Pacific Neuroscience Institute and renowned filmmaker Louie Schwartzberg.
Embracing the Psychedelic Renaissance: Pacific Neuroscience Institute Unveils New Center of Excellence
by PNI Experts
We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.
UFC Fighter’s Brain Injury Successfully Treated with Psychedelic Therapy
by Brianna Rauchman
Discover the transformative power of psychedelics for treating traumatic brain injuries (TBI) and mental health conditions. Witness former UFC fighter Ian McCall's inspiring recovery using psilocybin mushrooms. Join the conversation on revolutionizing mental health treatment with Daniel F. Kelly, MD, CEO of Pacific Neuroscience Institute (PNI) and board-certified neurosurgeon.
Magic Mushrooms: Pushing Frontiers in Mental Health Dr. Keith Heinzerling & Dr. Daniel Kelly On “Your Daily Dose with Kym Douglas”
by Anthony Effinger
This episode comes from the Saint John’s Health Center Foundation’s podcast, Your Daily Dose with Kym Douglas. Pacific Neuroscience Institute experts, Dr. Keith Heinzerling and Dr. Daniel Kelly discuss the Treatment & Research in Psychedelics (TRIP) program at PNI. Dr. Heinzerling, an addiction medicine specialist and TRIP director, and Dr. Kelly, director and one of the four founders of PNI describe how psychedelic-assisted therapy with compounds such as psilocybin from “magic mushrooms” in clinical trials can help treat conditions such as alcohol use disorder, anxiety, and depression. Listen to this episode to learn how these doctors envision psychedelic-assisted therapy transforming the current model of mental health care.
Last updated: August 31st, 2023